Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 23

    1.

    Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops.

    Abduljalil K, Diestelhorst M, Doroshyenko O, Lux A, Steinfeld A, Dinslage S, Süverkrüp R, Fuhr U.

    Eur J Clin Pharmacol. 2008 May;64(5):521-9. Epub 2008 Jan 25.PMID: 18219479 [PubMed - indexed for MEDLINE]Related articles

    2.

    [Three conventional eye drops versus a single lyophilisate. A comparative bioavailability study]

    Lux A, Dinslage S, Süverkrüp R, Maier S, Diestelhorst M.

    J Fr Ophtalmol. 2005 Feb;28(2):185-9. French. PMID: 15851952 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The ophthalmic lyophilisate carrier system (OLCS): development of a novel dosage form, freeze-drying technique, and in vitro quality control tests.

    Süverkrüp R, Grunthal S, Krasichkova O, Maier S, Weichselbaum A, Neff B, Diestelhorst M, Dinslage S, Lux A.

    Eur J Pharm Biopharm. 2004 Mar;57(2):269-77.PMID: 15018984 [PubMed - indexed for MEDLINE]Related articles

    4.

    Bioavailability of fluorescein from a new drug delivery system in human eyes.

    Steinfeld A, Lux A, Maier S, Süverkrüp R, Diestelhorst M.

    Br J Ophthalmol. 2004 Jan;88(1):48-53.PMID: 14693772 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A comparative bioavailability study of three conventional eye drops versus a single lyophilisate.

    Lux A, Maier S, Dinslage S, Süverkrüp R, Diestelhorst M.

    Br J Ophthalmol. 2003 Apr;87(4):436-40.PMID: 12642306 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Lyophilisates for drug delivery in ophthalmology: pharmacokinetics of fluorescein in the human anterior segment.

    Dinslage S, Diestelhorst M, Weichselbaum A, Süverkrüp R.

    Br J Ophthalmol. 2002 Oct;86(10):1114-7.PMID: 12234889 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Dose uniformity and redispersibility of pharmaceutical suspensions 2: assessment of three commercial erythromycin ethyl succinate oral liquids.

    Deicke A, Süverkrüp R.

    Eur J Pharm Biopharm. 2000 Jan;49(1):73-8.PMID: 10613930 [PubMed - indexed for MEDLINE]Related articles

    8.

    Dose uniformity and redispersibility of pharmaceutical suspensions. I: Quantification and mechanical modelling of human shaking behaviour.

    Deicke A, Süverkrüp R.

    Eur J Pharm Biopharm. 1999 Nov;48(3):225-32.PMID: 10612033 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration.

    Bagli M, Süverkrüp R, Quadflieg R, Höflich G, Kasper S, Möller HJ, Langer M, Barlage U, Rao ML.

    J Pharmacol Exp Ther. 1999 Nov;291(2):547-54.PMID: 10525070 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Dry Drops: a new preservative-free drug delivery system.

    Diestelhorst M, Grunthal S, Süverkrüp R.

    Graefes Arch Clin Exp Ophthalmol. 1999 May;237(5):394-8.PMID: 10333106 [PubMed - indexed for MEDLINE]Related articles

    11.

    Dose uniformity of ophthalmic suspensions.

    Diestelhorst M, Kwon KA, Süverkrup R.

    J Cataract Refract Surg. 1998 May;24(5):672-7.PMID: 9610452 [PubMed - indexed for MEDLINE]Related articles

    12.

    Production of artificial urinary stones from natural materials and their physical properties. First results.

    Heimbach D, Jacobs D, Winter P, Süverkrüp R, Hesse A.

    Scand J Urol Nephrol. 1997 Feb;31(1):9-13.PMID: 9060076 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Dosage problems in suspension eyedrops]

    Kwon KA, Diestelhorst M, Süverkrüp R.

    Klin Monbl Augenheilkd. 1996 Aug-Sep;209(2-3):144-9. German. PMID: 8992075 [PubMed - indexed for MEDLINE]Related articles

    14.

    Mean input times of three oral chlorprothixene formulations assessed by an enhanced least-squares deconvolution method.

    Bagli M, Süverkrüp R, Rao ML, Bode H.

    J Pharm Sci. 1996 Apr;85(4):434-9.PMID: 8901084 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.

    Bagli M, Rao ML, Höflich G, Kasper S, Langer M, Barlage U, Beneke M, Süverkrüp R, Möller HJ.

    Arzneimittelforschung. 1996 Mar;46(3):247-50.PMID: 8901143 [PubMed - indexed for MEDLINE]Related articles

    16.

    The extension grade: a model-unspecific rate characteristic derived from steady-state plasma level fluctuations.

    Süverkrüp R, Weiskirchen C.

    J Pharm Sci. 1994 Mar;83(3):410-4.PMID: 8207692 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Bioequivalence of theophylline retard capsules in children and relation of metabolism to administration route]

    Berdel D, Bonnacker I, Süverkrüp R, von Berg A, Buhr W.

    Pneumologie. 1990 Feb;44 Suppl 1:285-6. German. PMID: 2367391 [PubMed - indexed for MEDLINE]Related articles

    18.

    Numerical stability of pharmacokinetic deconvolution algorithms.

    Süverkrüp R, Bonnacker I, Raubach HJ.

    J Pharm Sci. 1989 Nov;78(11):948-54.PMID: 2621580 [PubMed - indexed for MEDLINE]Related articles

    19.

    Renal clearance of theophylline and its major metabolites: age and urine flow dependency in paediatric patients.

    Bonnacker I, Berdel D, Süverkrüp R, von Berg A.

    Eur J Clin Pharmacol. 1989;36(2):145-50.PMID: 2721539 [PubMed - indexed for MEDLINE]Related articles

    20.

    Total theophylline clearance in childhood: the influence of age-dependent changes in metabolism and elimination.

    Berdel D, Süverkrüp R, Heimann G, von Berg A, Liappis N, Stühmer A.

    Eur J Pediatr. 1987 Jan;146(1):41-3.PMID: 3582403 [PubMed - indexed for MEDLINE]Related articles

    21.

    Segmentally continuous input functions in linear multicompartment systems.

    Süverkrüp R.

    J Pharm Sci. 1985 Feb;74(2):136-41.PMID: 3989681 [PubMed - indexed for MEDLINE]Related articles

    22.

    Surgically affected sulfisoxazole pharmacokinetics in the morbidly obese.

    Garrett ER, Süverkrup RS, Eberst K, Yost RL, O'Leary JP.

    Biopharm Drug Dispos. 1981 Oct-Dec;2(4):329-65.PMID: 7317572 [PubMed - indexed for MEDLINE]Related articles

    23.

    Discontinuous absorption processes in pharmacokinetic models.

    Süverkrüp R.

    J Pharm Sci. 1979 Nov;68(11):1395-400.PMID: 512886 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...